HIGHFDA DRUG
Unique Pharmaceuticals Recalls Cetirizine Tablets Over Wrong ID Imprint
Unique Pharmaceuticals Labs recalled 9,936 bottles of Cetirizine Hydrochloride Tablets on September 12, 2025. The tablets were imprinted with the wrong ID, posing a potential health risk. Consumers should stop using the product immediately and seek guidance from healthcare providers.
CETIRIZINE HYDROCHLORIDE
Tablet/Capsules Imprinted